Fourth Quarter 2022 Highlights
Fourth Quarter 2022
Investor Presentation
Quarterly Highlights
Forward Looking Statement
In this presentation, we have included statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "estimate," "project," "plan," "believe," "anticipate," "intend," "planned," "potential" and similar expressions, or future or conditional verbs such as "will," "should," "would," "could," and "may," or the negative of those expressions or verbs, identify forward-looking statements. We caution readers that these statements are not guarantees of future performance. Forward-looking statements are not historical facts but instead represent only our beliefs regarding future events, which may by their nature be inherently uncertain and some of which may be outside our control. These statements may relate to plans and objectives with respect to the future, among other things which may change. We are alerting you to the possibility that our actual results may differ, possibly materially, from the expected objectives or anticipated results that may be suggested, expressed or implied by these forward-looking statements. Important factors that could cause our results to differ, possibly materially, from those indicated in the forward-looking statements include, among others, those discussed under "Risk Factors" .
Any or all of management's forward-looking statements here or in other publications may tuout to be incorrect and are based on management's current belief or opinions.
- inability to obtain reinsurance coverage on expected terms; (13) loss of key relationships for production of business in specialty property and casualty and insurance distribution businesses or the inability to secure such additional relationships to produce expected results; (14) the impact of catastrophic public health, environmental or natural events, or global or regional conflicts, on significant portions of our insured portfolio; (15) credit risks related to large single risks, risk concentrations and correlated risks; (16) risks associated with adverse selection as
Ambac's financial guarantee insurance portfolio runs off; (17) the risk thatAmbac's risk management policies and practices do not anticipate certain risks and/or the magnitude of potential for loss; (18) restrictive covenants in agreements and instruments that impairAmbac's ability to pursue or achieve its business strategies; (19) adverse effects on operating results or the Company's financial position resulting from measures taken to reduce financial guarantee risks in its insured portfolio; (20) disagreements or disputes withAmbac's insurance regulators; (21) loss of control rights in transactions for which we provide financial guarantee insurance; (22) inability to realize expected recoveries of financial guarantee losses; (23) risks attendant to the change in composition of securities in theAmbac's investment portfolio; (24) adverse impacts from changes in prevailing interest rates; (25) events or circumstances that result in the impairment of our intangible assets and/or goodwill that was recorded in connection withAmbac's acquisitions; (26) risks associated with the expected discontinuance of theLondon Inter-Bank Offered Rate; (27) factors that may negatively influence the amount of installment premiums paid toAmbac ; (28) the risk of litigation and regulatory inquiries or investigations, and the risk of adverse outcomes in connection therewith; (29) the Company's ability to adapt to the rapid pace of regulatory change; (30) actions of stakeholders whose interests are not aligned with broader interests ofAmbac's stockholders; (31) system security risks, data protection breaches and cyber attacks; (32) regulatory oversight ofAmbac Assurance UK Limited ("AmbacUK ") and applicable regulatory restrictions may adversely affect our ability to realize value from AmbacUK or the amount of value we ultimately realize; (33) failures in services or products provided by third parties;
- political developments that disrupt the economies where the Company has insured exposures; (35) our inability to attract and retain qualified executives, senior managers and other employees, or the loss of such personnel; (36) fluctuations in foreign currency exchange rates; (37) failure to realize our business expansion plans or failure of such plans to create value; (38) greater competition for our specialty property and casualty insurance business and/or our insurance distribution business; (39) loss or lowering of the AM Best rating for our property and casualty insurance company subsidiaries; (40) disintermediation within the insurance industry or greater competition from technology-based insurance solutions; (41) changes in law or in the functioning of the healthcare market that impair the business model of our accident and health managing general underwriter; and (42) other risks and uncertainties that have not been identified at this time.
2
Overview
|
|||
Everspan |
Cirrata |
Redgrove |
|
Specialty Property |
Insurance Distribution |
Strategic Investments in |
and Ambac |
|
|||
& |
Insurtech & Insurance Services |
||
|
Insurance Distribution Segment2 |
Corporate and Other2 |
|
Segment2 |
Segment2 |
1.
- 2. As reported in most recent Form 10-K
Specialty P&C: A Diversified, Capital Light Specialty Platform
Ambac's Specialty P&C Platform includes its growing program insurer (Everspan), specialty program insurance distribution segment (Cirrata) and strategic investments strategy (Redgrove)- The growth strategy for the Specialty P&C Business is to take advantage of the rapidly expanding
U.S. program market in a capital efficient manner - Everspan's program solutions utilize Managing General Agents (MGAs) and Managing General Underwriters (MGUs) as its primary distribution channel
- Cirrata acquires majority stakes in MGA/MGUs and brokers and incubates de novo MGA/MGUs; de novo MGA/MGUs may take advantage of underwriting capacity granted by Everspan, on either an admitted or surplus lines basis
Ambac made strategic investments in several tech-enabled and other insurance distribution businesses which are complimentary and/or synergistic with our Specialty P&C operations. These investments are also expected to provide attractive returns on investment.
Cirrata
Majority stakes in MGA/MGUs and brokers
Everspan
MGA/MGU program underwriting solutions
Specialty
P&C Platform
Creating value at every level of the MGA/MGU value chain
Redgrove
Minority stakes in
Insurtech and
insurance related
businesses
4
2023 Strategic Priorities
AFG |
|
Cirrata |
Legacy Financial |
Guarantee |
|||
- Grow and maximize shareholder value over medium and long term
- Strategically deploy capital to support and expand the Specialty P&C Platform
- Optimize the strategic value of corporate investments
Increasing Enterprise
Value
- Target GPW
+$250 million in 2023 growing to +$500million by 2024/20251,2 - Target mid-teens ROE at scale and over the cycle
- Projected profitability on a go-forward basis in 2H231,2
Compounding Book
Value
- Premiums placed
+$200 million targeted in 20231,2 - Target
+$45 million revenue in 20231,2 - Strive for double-digit organic growth
- Target +30%EBITDA margins1
Accelerating EBITDA
Growth
- De-riskand de-lever the balance sheet
- Regulatory operating and capital reassessment
- Evaluate all strategic options for value creation
Maximizing Economic
Value
Delivering Long-Term Value Through Re-deployment of Capital and Profitable Growth
1. Forward looking targets and projections subject to change. Targets and projections may not be realized and are not meant to provide guarantees of performance. Please refer to
- 2. Subject to market conditions
Attachments
Disclaimer
Consumer group appeals court loss in dispute over state insurance records [The San Diego Union-Tribune]
2022 Year End Review
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News